Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study

BACKGROUND: The optimal dose and fractionation scheme of stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) remains unclear due to different tolerated liver volumes and degrees of cirrhosis. In this study, we aimed to verify the dose-survival relationship to optimize dose...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Radiat Oncol
Päätekijät: Su, Ting-Shi, Liu, Qiu-Hua, Zhu, Xiao-Fei, Liang, Ping, Liang, Shi-Xiong, Lai, Lin, Zhou, Ying, Huang, Yong, Cheng, Tao, Li, Le-Qun
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2021
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8058965/
https://ncbi.nlm.nih.gov/pubmed/33882972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-021-01778-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia